Patents by Inventor Michael Mach

Michael Mach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Binding members for human cytomegalovirus
    Patent number: 9346874
    Abstract: The invention relates to binding members, especially antibody molecules, which may neutralize the biological effects of human cytomegalovirus (hCMV). The binding members may be useful for the treatment and prophylaxis of hCMV infection.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: May 24, 2016
    Assignee: 4-Antibody AG
    Inventors: Ulf Grawunder, Michael Mach, Luis Martin-Parras, Sonja Potzsch, Nadja Spindler, Heinrich Sticht, Anna-Katharina Wiegers, Thomas Winkler
  • BINDING MEMBERS FOR HUMAN CYTOMEGALOVIRUS
    Publication number: 20130089559
    Abstract: The invention relates to binding members, especially antibody molecules, which may neutralise the biological effects of human cytomegalovirus (hCMV). The binding members may be useful for the treatment and prophylaxis of hCMV infection.
    Type: Application
    Filed: June 22, 2012
    Publication date: April 11, 2013
    Applicant: 4-Antibody AG
    Inventors: Ulf Grawunder, Michael Mach, Luis Martin-Parras, Sonja Pötzsch, Nadja Spindler, Heinrich Sticht, Anna-Katharina Wiegers, Thomas Winkler
  • Structural phosphoprotein (pp28) of human cytomegalovirus (HCMV), the preparation and use thereof
    Patent number: 6733989
    Abstract: Structural phosphoprotein (pp28) of human cytomegalovirus (HCMV), the preparation and use thereof Expression of an SmaI fragment, which is about 1.0 kb in size, on the left-hand end of the HindIII R fragment makes it possible to synthesize, by genetic manipulation, a structural phosphoprotein of HCMV. This phosphoprotein, or immunogenic parts thereof, can be used as diagnostic aid or vaccine.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: May 11, 2004
    Assignee: Dade Behring Marburg GmbH
    Inventors: Michael Mach, Heidi Meyer, Michael Bröker, Leander Lauffer
  • Structural phosphoprotein (PP150) of human cytomegalovirus, and the preparation and use thereof
    Patent number: 5846733
    Abstract: The phosphorylated structural protein of molecular weight about 150 kd (pp 150) of human cytomegalovirus (HCMV) is highly immunogenic and is reliably recognised by human antisera. This protein can, after assignment and sequencing of the gene, be prepared, in whole or in immunogenic sections, by gene manipulation. Proteins of this type are suitable as reagents, for example in an ELISA, and as constituents of vaccines.
    Type: Grant
    Filed: April 28, 1995
    Date of Patent: December 8, 1998
    Assignee: Behring Diagnositcs GmbH
    Inventors: Gerhard Jahn, Birgit-Christine Scholl, Michael Broker, Michael Mach, Bernhard Fleckenstein, Bernd Traupe
  • Peptide of the structural phosphoprotein (pp 150) of human cytomegalovirus, and DNA encoding said peptide
    Patent number: 5728578
    Abstract: The phosphorylated structural protein of molecular weight about 150 kd (pp 150) of human cytomegalovirus (HCMV) is highly immunogenic and is reliably recognised by human antisera. This protein can, after assignment and sequencing of the gene, be prepared, in whole or in immunogenic sections, by gene manipulation. Proteins of this type are suitable as reagents, for example in an ELISA, and as constituents of vaccines.
    Type: Grant
    Filed: December 1, 1993
    Date of Patent: March 17, 1998
    Assignee: Behring Diagnostics GmbH
    Inventors: Gerhard Jahn, Birgit-Christine Scholl, Michael Broker, Michael Mach, Bernhard Fleckenstein, Bernd Traupe